Gossamer Bio
GOSS
GOSS
133 hedge funds and large institutions have $664M invested in Gossamer Bio in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less capital invested
Capital invested by funds: $688M → $664M (-$23.6M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less call options, than puts
Call options by funds: $3.51M | Put options by funds: $4.98M
Holders
133
Holding in Top 10
3
Calls
$3.51M
Puts
$4.98M
Top Buyers
| 1 | +$11.1M | |
| 2 | +$10.9M | |
| 3 | +$7.72M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.12M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.25M |
Top Sellers
| 1 | -$7.92M | |
| 2 | -$3.71M | |
| 3 | -$3.39M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$2.72M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.09M |